Department of Radiation Oncology, Jiangxi Key Laboratory of Translational Cancer Research, Jiangxi Cancer Hospital, Jiangxi Province, China.
School of Public Health, Fudan University, Shanghai, 200032, China.
Mini Rev Med Chem. 2024;24(8):786-792. doi: 10.2174/0113895575253875230922055711.
Long noncoding RNAs (lncRNAs) represent a large subgroup of RNA transcripts that lack the function of coding proteins and may be essential universal genes involved in carcinogenesis and metastasis. LncRNA metastasis-associated lung adenocarcinoma transcript 1 (lncRNAMALAT1) is overexpressed in various human tumors, including gliomas. However, the biological function and molecular mechanism of action of lncRNA-MALAT1 in gliomas have not yet been systematically elucidated. Accumulating evidence suggests that the abnormal expression of lncRNA-MALAT1 in gliomas is associated with various physical properties of the glioma, such as tumor growth, metastasis, apoptosis, drug resistance, and prognosis. Furthermore, lncRNAs, as tumor progression and prognostic markers in gliomas, may affect tumorigenesis, proliferation of glioma stem cells, and drug resistance. In this review, we summarize the knowledge on the biological functions and prognostic value of lncRNA-MALAT1 in gliomas. This mini-review aims to deepen the understanding of lncRNA-MALAT1 as a novel potential therapeutic target for the individualized precision treatment of gliomas.
长链非编码 RNA(lncRNA)是 RNA 转录本的一个大的亚群,它们缺乏编码蛋白质的功能,但可能是参与癌症发生和转移的基本普遍基因。lncRNA 转移相关肺腺癌转录本 1(lncRNAMALAT1)在各种人类肿瘤中过度表达,包括神经胶质瘤。然而,lncRNA-MALAT1 在神经胶质瘤中的生物学功能和作用机制尚未被系统阐明。越来越多的证据表明,lncRNA-MALAT1 在神经胶质瘤中的异常表达与神经胶质瘤的各种物理特性有关,如肿瘤生长、转移、凋亡、耐药性和预后。此外,lncRNA 作为神经胶质瘤中肿瘤进展和预后的标志物,可能影响神经胶质瘤干细胞的肿瘤发生、增殖和耐药性。在这篇综述中,我们总结了 lncRNA-MALAT1 在神经胶质瘤中的生物学功能和预后价值的知识。这篇综述旨在加深对 lncRNA-MALAT1 作为神经胶质瘤个体化精准治疗的新型潜在治疗靶点的理解。